KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Cash & Equivalents (2016 - 2025)

Cognex (CGNX) has disclosed Cash & Equivalents for 17 consecutive years, with $262.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 41.29% year-over-year to $262.9 million, compared with a TTM value of $262.9 million through Dec 2025, up 41.29%, and an annual FY2025 reading of $262.9 million, up 41.29% over the prior year.
  • Cash & Equivalents was $262.9 million for Q4 2025 at Cognex, up from $245.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $395.5 million in Q4 2023 and bottomed at $138.9 million in Q1 2024.
  • Average Cash & Equivalents over 5 years is $205.5 million, with a median of $186.1 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 48.68% in 2023, then plummeted 50.17% in 2024.
  • Year by year, Cash & Equivalents stood at $186.2 million in 2021, then fell by 2.57% to $181.4 million in 2022, then grew by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then skyrocketed by 41.29% to $262.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for CGNX at $262.9 million in Q4 2025, $245.9 million in Q3 2025, and $179.3 million in Q2 2025.